What are the potential side effects of BPC 157?

The potential side effects of BPC 157, as discussed by Andrew Huberman on the Huberman Lab, include:

1. Cancer Risk: BPC 157 promotes angiogenesis through the upregulation of VEGF (vascular endothelial growth factor), which can potentially increase tumor growth by enhancing blood flow to tumors. This poses a significant risk for individuals with existing cancer concerns or predispositions 1.

2. Growth Hormone Receptor Upregulation: BPC 157 can increase growth hormone receptors at injury sites, which, while beneficial for healing, might also lead to accelerated tumor growth in those with existing tumors 2.

3. System Safety:

   • High Safety Margin: BPC 157 shows a high safety margin in terms of lethal dosing levels in animal studies, but the therapeutic doses are typically much lower (300-500 micrograms subcutaneously, two to three times per week for eight weeks) 3.
     • 

       1

       BPC 157 Insights

       00:32:19
       
     • 

       2

       BPC 157 Insights

       00:30:29
       
     • 

       3

       BPC 157 Safety

       00:28:39
       
     • 

       4

       BPC 157 Insights

       00:23:17
       
     • 

       5

       Skin Youthfulness Insights

       01:29:00
       
   • Unclear Human Data: There is a lack of rigorous human clinical data, making it largely an experimental substance based on anecdotal evidence and animal studies 4.

4. Skin Sensitivity: Some compounds containing BPC 157 may increase sensitivity to light, making users more prone to sunburn and other light-induced skin issues, potentially causing redness or dryness 5.

Given these potential side effects, Andrew Huberman advises caution and thorough consideration before using BPC 157, especially monitoring for any signs of tumor growth or other adverse effects.